Brief: Aptose Presents Preliminary Clinical Data On CG-806
27/04/2020 14:20
April 27 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE PRESENTS PRELIMINARY CLINICAL DATA ON CG-806 AT
AACR
VIRTUAL ANNUAL MEETING 2020
* APTOSE BIOSCIENCES - FIRST-IN-HUMAN TESTS OF CG-806 ARE
BEING
CARRIED OUT IN PHASE 1A/B CLINICAL STUDY
* APTOSE BIOSCIENCES - NO DRUG-RELATED SEVERE ADVERSE EVENTS
OR
DOSE-LIMITING TOXICITY HAVE BEEN OBSERVED IN PATIENTS TO DATE IN
STUDY
Source text for Eikon: ID:nGNX1HcVhW
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting